Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Dorota Lebiedz-Odrobina"'
Autor:
Yoji Hoshina, Ka-Ho Wong, Jonathan Galli, Rae Bacharach, Julia Klein, Dorota Lebiedz-Odrobina, John W. Rose, Bryan Trump, Christopher Hull, John E. Greenlee, Stacey L. Clardy
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
ObjectiveTo assess the demographics, neurologic manifestations, comorbidities, and treatment of patients with seronegative primary Sjögren’s syndrome (pSS).Patients and methodsWe conducted a retrospective chart review on patients with seronegative
Externí odkaz:
https://doaj.org/article/f22133600ef74d2d9a1225bdda5087e5
Autor:
Rebecca S. Overbury, Gregory J. Stoddard, Jakrapun Pupaibool, Christopher B. Hansen, Dorota Lebiedz-Odrobina
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Retinal toxicity is a rare adverse event related to the use of hydroxychloroquine (HCQ). To address this, in 2016, the American Academy of Ophthalmology (AAO) issued guidelines recommending that HCQ not exceed 5 mg/kg/day. We anal
Externí odkaz:
https://doaj.org/article/3b4d99a2e2b44f7584058350b0383b8f
Autor:
Faris Alhomida, MD, David B. Beck, MD, PhD, Tracy I. George, MD, Andrew Shaffer, MD, Dorota Lebiedz-Odrobina, MD, Tibor Kovacsovics, MD, Lauren M. Madigan, MD
Publikováno v:
JAAD Case Reports, Vol 14, Iss , Pp 111-113 (2021)
Externí odkaz:
https://doaj.org/article/d1a583f5ce084c76bf6cdb5f1cbaaca6
Autor:
Sarah Luebker, Tracy M Frech, Shervin Assassi, Brian Skaug, Jessica K Gordon, Kimberly Lakin, Elana J Bernstein, Yiming Luo, Virginia D Steen, Ami A Shah, Laura K Hummers, Carrie Richardson, Duncan F Moore, Dinesh Khanna, Flavia V Castelino, Lorinda Chung, Puneet Kapoor, Faye N Hant, Victoria K Shanmugam, John M VanBuren, Jessica Alvey, Monica Harding, Ankoor Shah, Ashima Makol, Dorota Lebiedz-Odrobina, Julie K Thomas, Elizabeth R Volkmann, Jerry A Molitor, Nora Sandorfi
Publikováno v:
Rheumatology.
Objectives SSc is associated with increased health-care resource utilization and economic burden. The Collaborative National Quality and Efficacy Registry (CONQUER) is a US-based collaborative that collects longitudinal follow-up data on SSc patients
Publikováno v:
Archives of Pathology & Laboratory Medicine.
Context.— Antibodies to U1 ribonucleoprotein (U1RNP) were first described more than 50 years ago, and although clinically relevant for antinuclear antibody–associated connective tissue disease (ANA-CTD), test results are challenging to interpret.
Autor:
Dorota Lebiedz-Odrobina, Jamie L W Rhoads, Grace Skemp-Dymond, Lauren M. Zuromski, Anne E. Tebo
Publikováno v:
American Journal of Clinical Pathology. 157:506-509
Objectives To evaluate the performance characteristics of a line immunoassay (LIA) for the detection of Mi-2 antibodies associated with dermatomyositis (DM). Methods In total, 432 consecutive patient specimens were tested for Mi-2 antibodies concurre
Autor:
Joshua J Solomon, Sonye K Danoff, Felix A Woodhead, Shelley Hurwitz, Rie Maurer, Ian Glaspole, Paul F Dellaripa, Bibek Gooptu, Robert Vassallo, P Gerard Cox, Kevin R Flaherty, Huzaifa I Adamali, Michael A Gibbons, Lauren Troy, Ian A Forrest, Joseph A Lasky, Lisa G Spencer, Jeffrey Golden, Mary Beth Scholand, Nazia Chaudhuri, Mark A Perrella, David A Lynch, Daniel C Chambers, Martin Kolb, Cathie Spino, Ganesh Raghu, Hilary J Goldberg, Ivan O Rosas, Shana Haynes-Harp, Fernando Poli, Coimbatore Sree Vidya, Rebecca R. Baron, Timothy Clouser, Tracy Doyle, Anthony Maeda, Kristin B. Highland, Jemima F. Albayda, Sarah E. Collins, Karthik S. Suresh, John M. Davis, Andrew H. Limper, Isabel Amigues, Kristina Eliopoulos, Jeffery J. Swigris, Stephen Humphries, John C. Huntwork, Chris Glynn, Steve R. Duncan, Maria I. Danila, Marilyn K. Glassberg, Elana M. Oberstein, Elizabeth A. Belloli, Linda Briggs, Vivek Nagaraja, Linda Cholewa, Donna DiFranco, Edward Green, Christie Liffick, Tanvi Naik, Genevieve Montas, Dorota Lebiedz-Odrobina, Reba Bissell, Mark Wener, Lisa H. Lancaster, Leslie J. Crawford, Karmela Chan, Robert J. Kaner, Alicia Morris, Xiaoping Wu, Nader A. Khalidi, Christopher J. Ryerson, Alyson W. Wong, Charlene D. Fell, Sharon A. LeClercq, Mark Hyman, Shane Shapera, Shikha Mittoo, Shireen Shaffu, Karl Gaffney, Andrew M. Wilson, Shaney Barratt, Harsha Gunawardena, Rachel K. Hoyles, Joel David, Namrata Kewalramani, Toby M. Maher, Philip L. Molyneaux, Maria A. Kokosi, Matthew J. Cates, Mandizha Mandizha, Abdul Ashish, Gladstone Chelliah, Helen Parfrey, Muhunthan Thillai, Josephine Vila, Sophie V. Fletcher, Paul Beirne, Clair Favager, Jo Brown, Julie K. Dawson, Pilar Rivera Ortega, Sahena Haque, Pippa Watson, Jun K. Khoo, Karen Symons, Peter Youssef, John A. Mackintosh
Publikováno v:
The Lancet. Respiratory medicine.
Interstitial lung disease is a known complication of rheumatoid arthritis, with a lifetime risk of developing the disease in any individual of 7·7%. We aimed to assess the safety, tolerability, and efficacy of pirfenidone for the treatment of patien
Background Retinal toxicity is a rare adverse event related to the use of hydroxychloroquine (HCQ). To address this, in 2016, the American Academy of Ophthalmology (AAO) issued guidelines recommending that HCQ not exceed 5 mg/kg/day. We analyzed HCQ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73b735779cb2ccd7b158738e7c48e2f8
https://doi.org/10.21203/rs.3.rs-152712/v1
https://doi.org/10.21203/rs.3.rs-152712/v1
Publikováno v:
Rheumatology. 58:734-736
Publikováno v:
Ophthalmology. 124(12)